Positron Emission Tomographic Scanning Predicts Survival After Induction Chemotherapy for Esophageal Carcinoma
- 1 August 2007
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (2) , 393-400
- https://doi.org/10.1016/j.athoracsur.2007.03.094
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Scanning Affects Surgical Management in Selected Patients With High-Risk, Operable Breast CarcinomaAnnals of Surgical Oncology, 2006
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal CancerThe Annals of Thoracic Surgery, 2004
- Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal CarcinomaJournal of Clinical Oncology, 2001
- Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective StudyJournal of Clinical Oncology, 2001
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Endoscopic Ultrasound Cannot Determine Suitability for Esophagectomy After Aggressive Chemoradiotherapy for Esophageal CancerAmerican Journal of Gastroenterology, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Multimodality therapy for adenocarcinoma of the esophagusThe Annals of Thoracic Surgery, 1995
- Surgical therapy of oesophageal carcinomaBritish Journal of Surgery, 1990